Rolf Ostendorf
Moenchengladbach, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Long-Term Impact of Guselkumab on Skin, Sexuality, and Perceived Stigmatization in Patients With Psoriasis in Routine Clinical Practice: Week 76 Effectiveness and Safety Results From the Prospective German Multicenter G-EPOSS Study.
Journal: The Journal of dermatology
Published: March 25, 2025
KOH 5% solution versus diclofenac 3% for the treatment of actinic keratosis - Results from a three-armed RCT.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 24, 2025
Long-term follow-up of a randomized, double-blind, phase III, multi-centre study to evaluate the safety and efficacy of field-directed photodynamic therapy (PDT) of mild to moderate actinic keratosis using BF-200 ALA versus placebo and the BF-RhodoLED® lamp.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 28, 2024
Effectiveness, safety and impact of guselkumab on sexuality and perceived stigmatization in patients with psoriasis in routine clinical practice: Week 28 results from the prospective German multicentre G-EPOSS study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: October 03, 2023
Long-term clinical outcomes of imiquimod 5% cream vs. diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 10, 2019
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.
Journal: The British journal of dermatology
Published: February 04, 2018
Photodynamic therapy with a 5-ALA patch does not increase the risk of conversion of actinic keratoses into squamous cell carcinoma: Results of a multicentre non-interventional study.
Journal: Experimental dermatology
Published: December 20, 2017
A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
Journal: The British journal of dermatology
Published: February 15, 2016
Chronic spontaneous urticaria - a management pathway for patients with chronic spontaneous urticaria.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: April 29, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026